Validations: Closed Systems, Single-Use & Aseptic Controls

Templates: Closed System Qualification Packs

Templates: Closed System Qualification Packs Templates: Closed System Qualification Packs The advent of advanced therapeutics and biologics has prompted the pharmaceutical industry to adopt stringent validation frameworks to ensure product safety and efficacy. This step-by-step tutorial focuses on the critical aspects of qualification packs for closed systems, with a particular emphasis on aseptic processing, viral clearance validation, and regulatory compliance…

Continue Reading Templates: Closed System Qualification Packs

Templates: Closed System Qualification Packs

Templates: Closed System Qualification Packs for Aseptic and Viral Clearance Validation Introduction to Closed Systems in Pharmaceutical Validation Closed systems are essential components in the validation landscape, especially in the development and manufacturing of Advanced Therapy Medicinal Products (ATMPs) and biologics. With increasing regulatory scrutiny surrounding aseptic processing and viral clearance validation, understanding how to qualify these systems has become…

Continue Reading Templates: Closed System Qualification Packs

QS for Single-Use: Records and Governance

QS for Single-Use: Records and Governance QS for Single-Use: Records and Governance In the increasingly complex landscape of biologics and advanced therapy medicinal products (ATMPs), the necessity for comprehensive quality standards (QS) for single-use systems cannot be overstated. This article serves as a thorough guide to understanding the records and governance surrounding these systems, focusing on key areas such as…

Continue Reading QS for Single-Use: Records and Governance

QS for Single-Use: Records and Governance

QS for Single-Use: Records and Governance In the evolving landscape of biologics and advanced therapy medicinal products (ATMP), single-use systems have emerged as a critical component enabling manufacturers to address the complexities of aseptic processing. This detailed tutorial provides a comprehensive guide on the governance and record-keeping aspects essential for the validation of these systems, aligning with regulatory expectations from…

Continue Reading QS for Single-Use: Records and Governance

Aseptic Interventions: Minimization and Justification

Aseptic Interventions: Minimization and Justification Aseptic Interventions: Minimization and Justification Understanding Aseptic Processes in Biologics and ATMPs Aseptic processing is a critical component in the manufacturing of biologics and advanced therapy medicinal products (ATMPs). The goal of aseptic interventions is to minimize the risk of contamination during production and ensure product safety and efficacy. To meet regulatory expectations, organizations must…

Continue Reading Aseptic Interventions: Minimization and Justification

Aseptic Interventions: Minimization and Justification

Aseptic Interventions: Minimization and Justification Aseptic Interventions: Minimization and Justification Aseptic processing is a central element in the production of biologics and advanced therapy medicinal products (ATMPs). It relies heavily on stringent aseptic controls to ensure product safety and efficacy. This article serves as a comprehensive guide that details the principles, processes, and regulatory considerations associated with minimizing and justifying…

Continue Reading Aseptic Interventions: Minimization and Justification

Annex 1 Visual Inspection Links for ATMP

Annex 1 Visual Inspection Links for ATMP Advanced therapy medicinal products (ATMPs) are a revolutionary class of medicines that require meticulous validation processes to ensure their safety, efficacy, and quality. A key component in the quality assurance of ATMPs is the validation of aseptic controls outlined in regulatory standards such as Annex 1 of the EU GMP guidelines. This article…

Continue Reading Annex 1 Visual Inspection Links for ATMP

Annex 1 Visual Inspection Links for ATMP

Annex 1 Visual Inspection Links for ATMP Aseptic manufacturing processes for Advanced Therapy Medicinal Products (ATMPs) require stringent controls and validation to ensure product quality and patient safety. As defined by regulatory guidance from entities such as the US FDA, EMA, and MHRA, the importance of robust aseptic controls cannot be overstated. This guide serves as a comprehensive tutorial on…

Continue Reading Annex 1 Visual Inspection Links for ATMP

Closed System Deviations: Investigation & CAPA

Closed System Deviations: Investigation & CAPA Closed System Deviations: Investigation & CAPA Understanding Closed Systems and Their Importance in Aseptic Controls Closed systems represent a vital aspect of aseptic processing within pharmaceutical manufacturing, especially for biologics and advanced therapy medicinal products (ATMP). In these environments, maintaining sterility while handling sensitive products is paramount to ensuring safety and efficacy. The aseptic…

Continue Reading Closed System Deviations: Investigation & CAPA

Closed System Deviations: Investigation & CAPA

Closed System Deviations: Investigation & CAPA Closed System Deviations: Investigation & CAPA In the realm of biologics and advanced therapy medicinal products (ATMP), stringent validation protocols are essential for ensuring safety and efficacy. This article details a comprehensive approach to investigating closed system deviations, addressing corrective and preventive actions (CAPA) underpinned by regulatory standards such as those set forth by…

Continue Reading Closed System Deviations: Investigation & CAPA